FindMyKOL
Clinical trialNCT06888362CompletedPhase 1Interventional

Trial to Investigate GZ21T in Healthy Volunteers

SponsorGenzada Pharmaceuticals USA, Inc.Enrollment41Actinic Keratosis
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This is a double-blind, randomised, placebo-controlled trial designed to evaluate safety, tolerability, and pharmacokinetics (PK) after topical administration of single ascending doses of GZ21T in healthy volunteers.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Sweden
  • Ctc (clinical Trial Consultants) Ab

    Uppsala, Sweden, Sweden

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

GZ21T
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
19 Aug 2024
Primary completion
31 Mar 2025
Completion
31 Mar 2025
Last update posted
28 Jan 2026
Registered enrollment
41
Registry id
NCT06888362

Cross-registrations

EU-CTR / CTIS (EudraCT)2024-512893-86-00
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.